Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 05, 2022

SELL
$101.96 - $128.34 $199,433 - $251,033
-1,956 Closed
0 $0
Q4 2021

Feb 11, 2022

SELL
$106.37 - $130.68 $3,722 - $4,573
-35 Reduced 1.76%
1,956 $253,000
Q3 2021

Nov 12, 2021

SELL
$102.91 - $122.75 $26,756 - $31,915
-260 Reduced 11.55%
1,991 $225,000
Q2 2021

Aug 17, 2021

BUY
$83.84 - $104.76 $188,723 - $235,814
2,251 New
2,251 $233,000
Q1 2021

May 13, 2021

SELL
$78.68 - $90.67 $418,656 - $482,455
-5,321 Closed
0 $0
Q4 2020

Feb 09, 2021

BUY
$71.69 - $91.23 $61,510 - $78,275
858 Added 19.22%
5,321 $485,000
Q3 2020

Oct 22, 2020

BUY
$67.19 - $87.44 $64,233 - $83,592
956 Added 27.26%
4,463 $356,000
Q2 2020

Jul 06, 2020

BUY
$57.54 - $76.95 $145,000 - $193,914
2,520 Added 255.32%
3,507 $242,000
Q1 2020

Apr 27, 2020

BUY
$52.41 - $81.0 $419 - $648
8 Added 0.82%
987 $186,000
Q4 2019

Jan 13, 2020

SELL
$71.7 - $82.09 $6,883 - $7,880
-96 Reduced 8.93%
979 $228,000
Q3 2019

Oct 11, 2019

SELL
$61.55 - $75.43 $147,289 - $180,503
-2,393 Reduced 69.0%
1,075 $236,000
Q2 2019

Jul 30, 2019

SELL
$55.74 - $64.41 $7,803 - $9,017
-140 Reduced 3.88%
3,468 $641,000
Q1 2019

Apr 12, 2019

BUY
$47.89 - $64.05 $6,656 - $8,902
139 Added 4.01%
3,608 $690,000
Q4 2018

Feb 12, 2019

SELL
$46.41 - $56.94 $16,104 - $19,758
-347 Reduced 9.09%
3,469 $531,000
Q3 2018

Nov 16, 2018

BUY
$45.7 - $58.03 $12,019 - $15,261
263 Added 7.4%
3,816 $664,000
Q2 2018

Aug 14, 2018

SELL
$42.45 - $51.3 $35,742 - $43,194
-842 Reduced 19.16%
3,553 $517,000
Q1 2018

May 11, 2018

SELL
$37.19 - $47.45 $15,173 - $19,359
-408 Reduced 8.49%
4,395 $613,000
Q4 2017

Mar 13, 2018

BUY
$33.79 - $39.39 $162,293 - $189,190
4,803
4,803 $541,000

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $46.3B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Omni Star Financial Group, Inc. Portfolio

Follow Omni Star Financial Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Omni Star Financial Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Omni Star Financial Group, Inc. with notifications on news.